Prothena Corporation PLC Company Profile (NASDAQ:PRTA)

About Prothena Corporation PLC

Prothena Corporation PLC logoProthena Corporation Public Limited Company is a global biotechnology company. The Company is focused on the discovery, development and commercialization of immunotherapies for the treatment of diseases that involve protein misfolding or cell adhesion. The Company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis (PRX003). The Company has generated monoclonal antibodies that selectively bind to amyloidogenic (diseased) forms of the Transthyretin (TTR)-mediated amyloidosis (ATTR) protein. Its pipeline also includes late discovery-stage programs for which the Company is testing the efficacy of antibodies in preclinical models of diseases related to amyloid or cell adhesion. NEOD001 is a monoclonal antibody that specifically targets the amyloid that accumulates in AL amyloidosis.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: PRTA
  • CUSIP:
Key Metrics:
  • Previous Close: $53.45
  • 50 Day Moving Average: $51.04
  • 200 Day Moving Average: $54.31
  • 52-Week Range: $35,000,000.00 - $30.37
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -10.08
  • P/E Growth: 0.08
  • Market Cap: $1.87B
  • Outstanding Shares: 35,000,000
  • Beta: 2.52
Profitability:
  • Net Margins: -11,365.41%
  • Return on Equity: -32.65%
  • Return on Assets: -29.13%
Debt:
  • Current Ratio: 11.26%
  • Quick Ratio: 11.26%
Additional Links:
Companies Related to Prothena Corporation PLC:

Analyst Ratings

Consensus Ratings for Prothena Corporation PLC (NASDAQ:PRTA) (?)
Ratings Breakdown: 7 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $76.00 (42.19% upside)

Analysts' Ratings History for Prothena Corporation PLC (NASDAQ:PRTA)
Show:
DateFirmActionRatingPrice TargetDetails
2/15/2017WedbushReiterated RatingOutperform$77.00View Rating Details
12/20/2016SunTrust Banks, Inc.Initiated CoverageBuy$75.00View Rating Details
11/3/2016Deutsche Bank AGInitiated CoverageBuy$73.00View Rating Details
9/27/2016Credit Suisse GroupReiterated RatingBuy$65.00View Rating Details
8/4/2016Barclays PLCBoost Price TargetOverweight$60.00 -> $70.00View Rating Details
7/18/2016Royal Bank of CanadaReiterated RatingOutperform$95.00View Rating Details
3/15/2016Oppenheimer Holdings, Inc.Reiterated RatingOutperform$77.00View Rating Details
6/19/2015Ladenburg Thalmann Financial ServicesBoost Price TargetBuy$49.00 -> $57.00View Rating Details
(Data available from 2/26/2015 forward)

Earnings

Earnings History for Prothena Corporation PLC (NASDAQ:PRTA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/1/2017        
2/14/2017Q416($1.12)($1.41)$5.35 million$0.20 millionViewListenView Earnings Details
11/1/2016Q3($1.22)($1.26)$0.49 million$0.29 millionViewN/AView Earnings Details
8/2/2016Q2($0.91)($1.18)$0.39 million$0.33 millionViewN/AView Earnings Details
5/3/2016Q116($0.77)($0.81)ViewN/AView Earnings Details
2/18/2016Q215($0.81)($0.76)$0.39 million$0.31 millionViewListenView Earnings Details
11/2/2015($0.66)($0.73)ViewN/AView Earnings Details
8/4/2015Q2($0.56)($0.59)ViewN/AView Earnings Details
5/5/2015($0.59)($0.55)ViewN/AView Earnings Details
3/5/2015Q414($0.66)($0.48)$1.20 million$2.00 millionViewN/AView Earnings Details
11/3/2014Q314($0.60)($0.48)$1.13 million$1.50 millionViewN/AView Earnings Details
8/4/2014Q214$0.06$15.10 millionViewN/AView Earnings Details
5/6/2014$0.81$0.78ViewN/AView Earnings Details
3/6/2014Q113($0.52)ViewN/AView Earnings Details
3/28/2013Q412($0.82)$0.13 million$0.58 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Prothena Corporation PLC (NASDAQ:PRTA)
Current Year EPS Consensus Estimate: $-5.22 EPS
Next Year EPS Consensus Estimate: $-5.30 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.82)($0.82)($0.82)
Q2 20162($0.90)($0.90)($0.90)
Q3 20162($1.27)($0.99)($1.13)
Q4 20163($1.41)($1.12)($1.25)
Q1 20173($1.49)($1.28)($1.40)
Q2 20173($1.57)($0.57)($0.98)
Q3 20173($1.64)($1.34)($1.51)
Q4 20173($1.69)($0.71)($1.25)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Prothena Corporation PLC (NASDAQ:PRTA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Prothena Corporation PLC (NASDAQ:PRTA)
Insider Ownership Percentage: 3.70%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/4/2017Arthur W HomanInsiderSell3,125$52.25$163,281.25View SEC Filing  
11/28/2016Dennis J SelkoeDirectorSell5,000$62.42$312,100.00View SEC Filing  
11/9/2016Gene G KinneyInsiderSell8,548$55.32$472,875.36View SEC Filing  
10/21/2016Gene G KinneyInsiderSell20,619$55.10$1,136,106.90View SEC Filing  
10/13/2016Karin L WalkerInsiderSell5,000$54.23$271,150.00View SEC Filing  
9/19/2016Karin L WalkerInsiderSell12,000$61.10$733,200.00View SEC Filing  
9/1/2016Arthur W HomanInsiderSell3,125$52.16$163,000.00View SEC Filing  
7/20/2016Arthur W HomanInsiderSell9,375$52.14$488,812.50View SEC Filing  
5/24/2016Dennis J SelkoeDirectorSell5,000$45.00$225,000.00View SEC Filing  
4/13/2016Karin L WalkerInsiderSell4,000$45.11$180,440.00View SEC Filing  
4/4/2016Dennis J SelkoeDirectorSell5,000$45.00$225,000.00View SEC Filing  
1/13/2016Karin L. WalkerinsiderSell4,000$50.96$203,840.00View SEC Filing  
12/9/2015Tara NickersoninsiderSell10,000$66.17$661,700.00View SEC Filing  
12/9/2015Tran NguyenCFOSell30,000$66.17$1,985,100.00View SEC Filing  
12/1/2015Dennis J. SelkoeDirectorSell3,125$68.74$214,812.50View SEC Filing  
11/27/2015Christopher S. HenneyDirectorSell5,000$75.00$375,000.00View SEC Filing  
11/25/2015Lars EkmanDirectorSell30,000$73.35$2,200,500.00View SEC Filing  
11/13/2015Martin KollerinsiderSell30,000$65.03$1,950,900.00View SEC Filing  
11/2/2015Arthur W. HomaninsiderSell3,125$52.14$162,937.50View SEC Filing  
10/29/2015Christopher S. HenneyDirectorSell5,000$55.00$275,000.00View SEC Filing  
9/9/2015Tara NickersoninsiderSell10,000$56.06$560,600.00View SEC Filing  
9/2/2015Martin KollerinsiderSell30,000$55.56$1,666,800.00View SEC Filing  
9/1/2015Dennis J. SelkoeDirectorSell3,125$55.45$173,281.25View SEC Filing  
8/20/2015Dale B. SchenkCEOSell30,000$56.65$1,699,500.00View SEC Filing  
8/12/2015Karin L WalkerInsiderSell7,000$62.06$434,420.00View SEC Filing  
6/9/2015Tara NickersonInsiderSell12,000$44.41$532,920.00View SEC Filing  
3/20/2015Tara NickersonInsiderSell13,000$39.99$519,870.00View SEC Filing  
3/9/2015Dennis J SelkoeDirectorSell3,125$25.56$79,875.00View SEC Filing  
8/12/2014Karin L WalkerInsiderSell2,500$20.74$51,850.00View SEC Filing  
8/7/2014Arthur W HomanInsiderBuy2,000$19.12$38,240.00View SEC Filing  
6/6/2014Karin L WalkerInsiderSell8,000$21.58$172,640.00View SEC Filing  
5/12/2014Dale SchenkCEOBuy8,000$20.79$166,320.00View SEC Filing  
5/12/2014Tara NickersonInsiderBuy1,656$21.00$34,776.00View SEC Filing  
5/9/2014Gene KinneyInsiderBuy2,500$19.54$48,850.00View SEC Filing  
5/9/2014Tran NguyenCFOBuy2,200$19.61$43,142.00View SEC Filing  
2/3/2014Co Plc Perrigomajor shareholderSell3,182,253$24.96$79,429,034.88View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Prothena Corporation PLC (NASDAQ:PRTA)
DateHeadline
News IconDirector of Prothena Corporation plc (NASDAQ:PRTA), Henney Christopher S, sells 4,011 shares worth $228,880 (NASDAQ:PRTA)
empowerednews.net - February 23 at 12:30 AM
News IconAnalysts Peer Into Their Crystal Balls For Prothena Corporation plc (NASDAQ:PRTA): Where Is It headed? - Winfield Review (NASDAQ:PRTA)
winfieldreview.com - February 22 at 9:24 AM
News IconAre Analysts Optimistic About Where Prothena Corporation plc (NASDAQ:PRTA) is Heading? - Winfield Review (NASDAQ:PRTA)
winfieldreview.com - February 18 at 8:02 AM
capitalcube.com logoProthena Corp. Plc :PRTA-US: Earnings Analysis: 2016 By the Numbers : February 17, 2017 (NASDAQ:PRTA)
www.capitalcube.com - February 17 at 8:09 PM
finance.yahoo.com logoProthena (PRTA) Reports Wider-than-Expected Loss in Q4 (NASDAQ:PRTA)
finance.yahoo.com - February 16 at 6:56 PM
capitalcube.com logoProthena Corp. Plc :PRTA-US: Earnings Analysis: Q4, 2016 By the Numbers : February 16, 2017 (NASDAQ:PRTA)
www.capitalcube.com - February 16 at 6:56 PM
4-traders.com logoProthena : Reports Fourth Quarter and Full Year 2016 Financial Results, and Provides Financial Guidance and R&D Update (NASDAQ:PRTA)
www.4-traders.com - February 15 at 4:53 AM
nasdaq.com logoAXSM On Fast Track, MRK Halts Alzheimer's Drug Study, HOLX Snaps Up CYNO (NASDAQ:PRTA)
www.nasdaq.com - February 15 at 4:53 AM
biz.yahoo.com logoQ4 2016 Prothena Corporation PLC Earnings Release - After Market Close (NASDAQ:PRTA)
us.rd.yahoo.com - February 15 at 4:53 AM
us.rd.yahoo.com logoProthena Reports Fourth Quarter and Full Year 2016 Financial Results, and Provides Financial Guidance and R&D Update (NASDAQ:PRTA)
us.rd.yahoo.com - February 15 at 4:53 AM
us.rd.yahoo.com logo4:09 pm Prothena misses by $0.20, misses on revs (NASDAQ:PRTA)
us.rd.yahoo.com - February 15 at 4:53 AM
biz.yahoo.com logoPROTHENA CORP PLC Files SEC form 8-K, Results of Operations and Financial Condition (NASDAQ:PRTA)
us.rd.yahoo.com - February 15 at 4:53 AM
finance.yahoo.com logoEdited Transcript of PRTA earnings conference call or presentation 14-Feb-17 9:30pm GMT (NASDAQ:PRTA)
finance.yahoo.com - February 15 at 4:53 AM
News IconProthena Corporation PLC (PRTA) Releases Earnings Results, Misses Expectations By $-0.20 EPS - Highland Mirror (NASDAQ:PRTA)
www.highlandmirror.com - February 14 at 11:52 PM
sg.finance.yahoo.com logoProthena reports 4Q loss (NASDAQ:PRTA)
sg.finance.yahoo.com - February 14 at 11:52 PM
News IconFMI Releases New Report on the Ethylene Dichloride Market 2015-2025 (NASDAQ:PRTA)
reports.pr-inside.com - February 10 at 9:28 PM
finanznachrichten.de logoProthena Corporation plc: Prothena to Participate in the Leerink Partners 6th Annual Global Healthcare Conference (NASDAQ:PRTA)
www.finanznachrichten.de - February 8 at 9:07 PM
us.rd.yahoo.com logoBlog Coverage VBI Vaccines Receives Positive Scientific Advice from EMA's Committee for Medicinal Products for Human Use its 3rd Generation Hepatitis B Vaccine (NASDAQ:PRTA)
us.rd.yahoo.com - February 8 at 9:07 PM
finance.yahoo.com logoProthena to Participate in the Leerink Partners 6th Annual Global Healthcare Conference (NASDAQ:PRTA)
finance.yahoo.com - February 8 at 9:07 PM
finance.yahoo.com logoCan Prothena (PRTA) Pull a Surprise This Earnings Season? (NASDAQ:PRTA)
finance.yahoo.com - February 8 at 9:07 PM
finance.yahoo.com logoProthena to Report Fourth Quarter and Full Year 2016 Financial Results and Host Webcast Conference Call on February 14 (NASDAQ:PRTA)
finance.yahoo.com - February 1 at 10:02 PM
News IconProthena Corp Plc PRTA Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:PRTA)
www.bioportfolio.com - January 24 at 8:28 AM
investors.com logoProthena Grabbing At Chunk Of $201B Immunotherapy Market: CEO Exclusive (NASDAQ:PRTA)
www.investors.com - January 20 at 8:13 PM
News IconStock Momentum Skidding to a Halt For Prothena Corporation plc (NASDAQ:PRTA) - Wall Street Beacon (NASDAQ:PRTA)
wsbeacon.com - January 18 at 12:46 AM
seekingalpha.com logoProthena (PRTA) Presents At 35th Annual J.P. Morgan Healthcare Conference (NASDAQ:PRTA)
seekingalpha.com - January 14 at 4:51 AM
News IconWill The Needle Move For Prothena Corporation plc (NASDAQ:PRTA) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:PRTA)
wsbeacon.com - January 13 at 8:01 AM
News IconStock Reaching Most Volatile List Today: Prothena Corporation plc (NASDAQ:PRTA) - Wall Street Beacon (NASDAQ:PRTA)
wsbeacon.com - January 12 at 1:02 AM
News IconStock Getting Tripped Up In Session: Prothena Corporation plc (NASDAQ:PRTA) - Wall Street Beacon (NASDAQ:PRTA)
wsbeacon.com - January 12 at 1:02 AM
capitalcube.com logoProthena Corp. Plc – Value Analysis (NASDAQ:PRTA) : January 10, 2017 (NASDAQ:PRTA)
www.capitalcube.com - January 10 at 8:18 PM
marketexclusive.com logoInsider Trading Activity Prothena Corporation PLC (NASDAQ:PRTA) – Insider Sold 3125 shares of Stock - Market Exclusive (NASDAQ:PRTA)
marketexclusive.com - January 9 at 8:00 PM
capitalcube.com logoProthena Corp. Plc breached its 50 day moving average in a Bullish Manner : PRTA-US : January 9, 2017 (NASDAQ:PRTA)
www.capitalcube.com - January 9 at 8:00 PM
marketexclusive.com logoInsider Trading Activity Prothena Corporation PLC (NASDAQ:PRTA) – Insider Sold 3,125 shares of Stock (NASDAQ:PRTA)
marketexclusive.com - January 8 at 7:03 PM
News IconNotable Insider Report: Arthur Homan Sold 3,125 Shares of Prothena Corporation PLC (NASDAQ:PRTA) (NASDAQ:PRTA)
www.whatsonthorold.com - January 6 at 8:04 PM
globenewswire.com logoProthena to Participate in the J.P. Morgan Healthcare Conference - GlobeNewswire (press release) (NASDAQ:PRTA)
globenewswire.com - January 5 at 1:59 AM
finanznachrichten.de logoProthena Corporation plc: Prothena to Participate in the J.P. Morgan Healthcare Conference (NASDAQ:PRTA)
www.finanznachrichten.de - January 4 at 8:12 PM
News IconHARLEY-DAVIDSON, INC. TO REPORT FOURTH QUARTER AND YEAR-END [..] (NASDAQ:PRTA)
www.pr-inside.com - January 4 at 8:12 PM
finance.yahoo.com logoProthena to Participate in the J.P. Morgan Healthcare Conference (NASDAQ:PRTA)
finance.yahoo.com - January 4 at 8:12 PM
News IconProthena Corporation Plc (NASDAQ:PRTA) – Latest Broker Consensus - NewsDen (NASDAQ:PRTA)
newsden.net - December 30 at 8:56 AM
nasdaq.com logoCommit To Purchase Prothena Corp At $35, Earn 15.1% Annualized Using Options - Nasdaq (NASDAQ:PRTA)
www.nasdaq.com - December 28 at 9:38 AM
nasdaq.com logoCommit To Purchase Prothena Corp At $35, Earn 15.1% Annualized Using Options (NASDAQ:PRTA)
www.nasdaq.com - December 27 at 7:07 PM
nasdaq.com logoPRTA Crosses Below Key Moving Average Level (NASDAQ:PRTA)
www.nasdaq.com - December 22 at 7:42 PM
us.rd.yahoo.com logoCoverage initiated on Prothena by SunTrust (NASDAQ:PRTA)
us.rd.yahoo.com - December 21 at 8:11 PM
streetinsider.com logoProthena Corp. (PRTA) Names Carol Karp as Chief Regulatory Officer - StreetInsider.com (NASDAQ:PRTA)
www.streetinsider.com - December 16 at 2:08 AM
streetinsider.com logoProthena Corp. (PRTA) Names Carol Karp as Chief Regulatory Officer (NASDAQ:PRTA)
www.streetinsider.com - December 15 at 9:07 PM
finance.yahoo.com logoProthena Announces Appointment of Chief Regulatory Officer (NASDAQ:PRTA)
finance.yahoo.com - December 15 at 9:07 PM
globenewswire.com logoData Previously Presented in 2015 at 19th International Congress of Parkinson's Disease and Movement Disorders (NASDAQ:PRTA)
globenewswire.com - December 14 at 12:45 AM
streetinsider.com logoProthena Corp. (PRTA) Announced Publication of Results From Phase 1 Single Ascending Dose Study of PRX002 (NASDAQ:PRTA)
www.streetinsider.com - December 14 at 12:45 AM
us.rd.yahoo.com logoFirst-In-Human Assessment of PRX002, Prothena’s Anti-Alpha Synuclein Antibody for Parkinson’s Disease, Published in Movement Disorders Journal (NASDAQ:PRTA)
us.rd.yahoo.com - December 14 at 12:45 AM
streetinsider.com logoProthena Corp. (PRTA) Announced Publication of Results From Phase 1 Single Ascending Dose Study of PRX002 - StreetInsider.com (NASDAQ:PRTA)
www.streetinsider.com - December 13 at 7:43 PM
finance.yahoo.com logo4:07 pm Prothena announces the publication of previously disclosed clinical results from a Phase 1 single ascending dose study in healthy volunteers of PRX002 in the peer-reviewed journal Movement Disorders (NASDAQ:PRTA)
finance.yahoo.com - December 13 at 7:43 PM

Social

What is Prothena Corporation PLC's stock symbol?

Prothena Corporation PLC trades on the NASDAQ under the ticker symbol "PRTA."

Where is Prothena Corporation PLC's stock going? Where will Prothena Corporation PLC's stock price be in 2017?

7 brokers have issued 12 month target prices for Prothena Corporation PLC's stock. Their forecasts range from $65.00 to $95.00. On average, they anticipate Prothena Corporation PLC's stock price to reach $76.00 in the next year.

When will Prothena Corporation PLC announce their earnings?

Prothena Corporation PLC is scheduled to release their next quarterly earnings announcement on Monday, May, 1st 2017.

Who owns Prothena Corporation PLC stock?

Prothena Corporation PLC's stock is owned by a number of of institutional and retail investors. Top institutional investors include FMR LLC (15.00%), State Street Corp (3.15%), Palo Alto Investors LLC (2.88%), Pinnacle Associates Ltd. (1.18%), Loomis Sayles & Co. L P (0.57%) and Eventide Asset Management LLC (0.35%). Company insiders that own Prothena Corporation PLC stock include Arthur W Homan, Christopher S Henney, Dale B Schenk, Dennis J Selkoe, Gene G Kinney, Karin L Walker, Lars Ekman, Martin Koller, Tara Nickerson and Tran Nguyen.

Who sold Prothena Corporation PLC stock? Who is selling Prothena Corporation PLC stock?

Prothena Corporation PLC's stock was sold by a variety of institutional investors in the last quarter, including Turner Investments LLC, Pinnacle Associates Ltd., Allianz Asset Management AG, Guggenheim Capital LLC, Putnam Investments LLC, AQR Capital Management LLC and Commerzbank Aktiengesellschaft FI. Company insiders that have sold Prothena Corporation PLC stock in the last year include Arthur W Homan, Dennis J Selkoe, Gene G Kinney and Karin L Walker.

Who bought Prothena Corporation PLC stock? Who is buying Prothena Corporation PLC stock?

Prothena Corporation PLC's stock was purchased by a variety of institutional investors in the last quarter, including Loomis Sayles & Co. L P, Palo Alto Investors LLC, Opaleye Management Inc., Handelsbanken Fonder AB, FMR LLC, State Street Corp, Russell Investments Group Ltd. and Denver Investment Advisors LLC.

How do I buy Prothena Corporation PLC stock?

Shares of Prothena Corporation PLC can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Prothena Corporation PLC stock cost?

One share of Prothena Corporation PLC stock can currently be purchased for approximately $53.45.

Prothena Corporation PLC (NASDAQ:PRTA) Chart for Sunday, February, 26, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Prothena Corporation PLC (NASDAQ:PRTA)

Earnings History Chart

Earnings by Quarter for Prothena Corporation PLC (NASDAQ:PRTA)

Dividend History Chart

Dividend Payments by Quarter for Prothena Corporation PLC (NASDAQ:PRTA)

Last Updated on 2/26/2017 by MarketBeat.com Staff